Benign FGB (148Lys→Asn, and 448Arg→Lys), and novel causative γ211Tyr→His mutation distinguished by time of flight mass spectrometry in a family with hypofibrinogenaemia

 

 Buy Article Permissions and Reprints

Summary

We describe a novel procedure for the direct analysis of plasma fibrinogen by HPLC time of flight (TOF) mass spectrometry and apply it to the investigation of a family with hypofibrinogenaemia. Electrospray TOF analysis provided much higher resolution than was possible with our previous quadrupole analyser and revealed three different mass changes within the fibrinogen Bβ and γ chains of the family. It also demonstrated the actual hypofibrinogenaemia phenotype was caused by an aberrant _ chain (-23 Da) which was expressed at a diminished ratio of 0.2:1 relative to γ^A and co-inherited with a second coequally expressed Bβ variant (Bβ^M /Bβ^A, 1:1). Co-segregation was confirmed by gene analysis that showed the affected father and son had a very rare Bβ148Lys→Arg mutation (-14 Da) inherited together with a unique new γ211Tyr→His mutation (-26 Da). This latter causative substitution occurs at a site that is absolutely conserved across all fibrinogen chains and preserved across all species. TOF analysis also identified a variant B_ chain (54,186 Da) that was coequally expressed with normal Bβ chains (54,213 Da) in the unaffected mother.

• References

• 1 Tennent GA, Brennan SO, Stangou AJ. et al. Human plasma fibrinogen is synthesized in the liver.. Blood 2007; 109: 1971-1974.
  CrossrefPubMedGoogle Scholar
• 2 Huang S, Cao Z, Chung DW. et al. The role of βγ and αγ complexes in the assembly of human fibrinogen.. J Biol Chem 1996; 271: 27942-27947.
  CrossrefPubMedGoogle Scholar
• 3 Mizuochi T, Taniguchi T, Asami Y. et al. Comparative studies on the structure of the charbohydrate moieties of human fibrinogen and abnormal fibrinogen Na-goya.. J Biochem 1982; 92: 283-293.
  CrossrefPubMedGoogle Scholar
• 4 Hanss M, Biot F. A database for human fibrinogen variants.. Ann NY Acad Sci 2001; 936: 89-90. Available at: http://www.geht.org/databaseang/fibrinogen .
  CrossrefPubMedGoogle Scholar
• 5 Haverkate F, Samama M. Familial dysfibrinogenaemia and thrombophilia. Report on a study of the SSC subcommittee on fibrinogen.. Thromb Haemost 1995; 73: 151-161.
  Article in Thieme ConnectPubMedGoogle Scholar
• 6 Brennan SO, Davis RL, Conard K. et al. Novel fibrinogen mutation γ314ThrPro (fibrinogen AI du-Pont) associated with hepatic fibrinogen storage disease and hypofibrinogenaemia.. Liver Int 2010; 30: 1541-1547.
  CrossrefPubMedGoogle Scholar
• 7 Lefebvre P, Velasco PT, Dear A. et al. Coagulopathy in compound heterozygotes with the fibrinogen Aa ivs-4 mutation and AaGln328 truncation (fibrinogen Keokuk).. Blood 2004; 103: 2571-2576.
  CrossrefPubMedGoogle Scholar
• 8 Davis RL, Homer VM, George PM. et al. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif which leads to aberrant mRNA splicing and afibrinogenemia that can be corrected in vitro with antisense oligo-nucleotide treatment.. Human Mutation 2009; 30: 221-227.
  CrossrefPubMedGoogle Scholar
• 9 Brennan SO, Hammonds B, George PM. Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (Aa20 Val-Asp).. J Clin Invest 1995; 96: 2854-2858.
  CrossrefPubMedGoogle Scholar
• 10 Schmidt D, Brennan SO. Modified form of the Fibrinogen Bβ Chain (des-Gln Bβ); a potential long term marker of pancreatitis.. Clin Chem 2007; 53: 2105-2111.
  CrossrefPubMedGoogle Scholar
• 11 Brennan SO, Meera C. Hypodysfibrinogenaemia and thrombosis in association with a new fibrinogen γ chain with two mutations ^114Tyr->His, and γ320Asp deleted).. Thromb Haemost 2013; 109: 1180-1182.
  Article in Thieme ConnectPubMedGoogle Scholar
• 12 Brennan SO, Davis RL. Substitution ^335Trp->Arg) in fibrinogen Fremantle causes diminished γ chain expression and increased sialic acid content.. Thromb Haemost 2010; 104: 1274-1276.
  Article in Thieme ConnectPubMedGoogle Scholar
• 13 Maghzal G, Brennan SO, Fellowes AP. et al. Familial hypofibrinogenaemia associated with heterozygous substitution of a conserved arginine residue; Bbeta255 Arg-His (Fibrinogen Merivale).. Biochim Biophys Acta 2003; 1645: 146-151.
  CrossrefPubMedGoogle Scholar
• 14 Yee VC, Pratt KP, Cote HCF. et al. Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen.. Structure 1997; 5: 125-138.
  CrossrefPubMedGoogle Scholar
• 15 Hanss M, French P, Vinciguerra C. et al. Four cases of hypofibrinogenemia associated with four novel mutations.. J Thromb Haemost 2005; 3: 2347-2349.
  CrossrefPubMedGoogle Scholar
• 16 Brennan SO, Sheen CR, George PM. Novel γ230 Asn- Asp Substitution in Fibri-nogen Middlemore Associated Hypofibrinogenaemia.. Thromb Haemost 2005; 93: 1196-1197.
  Article in Thieme ConnectPubMedGoogle Scholar
• 17 Vu D, de Moerloose P, Batorova A. et al. Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the gamma chain globular domain impairing fibrinogen secretion.. J Med Genet 2005; 42: e57.
  CrossrefPubMedGoogle Scholar
• 18 Davis RL, Mosesson MW, Kerlin B. et al. Fibrinogen Columbus: a novel γ Gly200Val mutation causing hypofibrinogenaemia in a family with associated thrombophilia.. Haematologica 2007; 94: 1151-1152.
  CrossrefPubMedGoogle Scholar
• 19 PolyPhen-2 prediction of functional effects of human nsSNPs.. Available at: http://genetics.bwh.harvard.edu/pph2 .
  PubMedGoogle Scholar